Related Experiment Video
Updated: Jan 14, 2026

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
Biologics for Subchondral Bone Injuries
Ignacio Dallo1, Pedro Bernáldez2, José Fabio Lana3
1Department of Orthopaedic Surgery and Sports Medicine Sport Me Medical Center, Unit of Biological Therapies and MSK Interventionism, C. Tabladilla, 2, 41013 Sevilla; Centro Universitario Max Plank, OrthoRegen, Indaiatuba, Av. Nove de Dezembro, 460 - Jardim Pedroso, Indaiatuba - SP, 13343-060, Brasil.
None:
Subchondral bone pathology (SBP) includes a wide range of pathologies, including trauma, postcartilage surgery, osteoarthritis, transient bone marrow syndromes, spontaneous insufficiency fractures, and osteonecrosis. They show joint MRI findings termed bone marrow lesions. However, the etiology and evolution of SBP in multiple conditions remain unclear. A key factor to address in a patient with BME is the distinction between reversible and irreversible lesions. MRI plays a significant role in the differential diagnosis based on recognizable typical patterns considered together with coexistent abnormalities, age, and clinical history. This article will focus on the current understanding of the biologics of SBP.

